COMP <GO>
CLX vs HWKN // EV/EBITDA & P/E VALUATION
Clorox Company (NYSE) VS. Hawkins Inc. (NASDAQ) • 15-METRIC TALLY: CLX 9
— HWKN 3
▲ EV/EBITDA & P/E VALUATION LEADER: CLX
LAST: $88.67 (+2.11%) • MKT CAP: $10.72B
valuation
10.9x
LAST: $153.73 (-0.21%) • MKT CAP: $3.20B
valuation
20.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLX VS. HWKN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLX | HWKN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.20% | 22.60% | +22.60 | CLX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.20% | 12.40% | +24.80 | CLX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.9x | 20.2x | -9.30 | CLX | /valuation <GO> |
| Free Cash Flow Yield | 7.10% | 2.69% | +4.41 | CLX | /fcf-yield <GO> |
| Operating Margin | 14.20% | 11.20% | +3.00 | CLX | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 7.50% | +4.10 | CLX | /net-margins <GO> |
| Revenue Growth (YoY) | 0.20% | 11.20% | -11.00 | HWKN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.61% | 0.49% | +5.12 | CLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 6.57 | -3.64 | HWKN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 78.0 | -22.42 | HWKN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.1x | 36.5x | -24.40 | CLX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.72B | $3.20B | $7.53B | CLX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLX REV | HWKN REV | CLX GROSS % | HWKN GROSS % | CLX FCF | HWKN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.10B | $1.08B | 45.2% | 22.6% | $761.0M | $86.1M |
| FY 2024 | $7.09B | $974.4M | 43.0% | 23.1% | $483.0M | $70.0M |
| FY 2023 | $7.39B | $919.2M | — | — | $825.5M | $159.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLX // BETA 0.93
HWKN // BETA —